This aligns with previous reports that DEK silencing by RNAi in glioblastomas and HeLa cells increases p53 up-regulation and subsequent CDKN1A/p21 expression whereas exogenous DEK silences TP53 (p53) expression (44, 45, 46). This evidence concerns the gene CDKN1A and glioblastoma.